ArticleCureus2026
Supracondylar Humerus Fractures in Children With Vascular Compromise: A Report of Two Cases and Review of Literature.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Supracondylar humerus fractures are the most common pediatric elbow fractures and may rarely be associated with vascular compromise. We present two pediatric cases of displaced left supracondylar humerus fractures complicated by arterial injury. A four-year-old boy developed absent radial and ulnar pulses following fracture fixation and underwent urgent thrombectomy with Fogarty catheterization using a Fogarty arterial embolectomy catheter (Edwards Lifesciences, Irvine, CA, USA), resulting in immediate restoration of distal perfusion. An 11-year-old girl presented with brachial artery entrapment within the fracture site and was successfully treated with surgical release and vascular repair. Both patients were managed with external fixation (DePuy Synthes, West Chester, PA, USA) and received postoperative weight-adjusted rivaroxaban (Xarelto®; Bayer AG, Leverkusen, Germany) as part of individualized postoperative management for three months. At follow-up, both patients demonstrated complete recovery of hand function with intact distal perfusion and no neurological deficits. These cases highlight the importance of early recognition of vascular compromise, prompt surgical intervention, and interdisciplinary management in preventing ischemic complications and optimizing functional recovery. However, evidence regarding postoperative anticoagulation in pediatric vascular trauma remains limited, and standardized protocols are currently lacking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.